Pintova S - Search Results

1

Impact of High-Quality Goals-of-Care Discussions on Oncologist Productivity.

Pintova S, Leibrandt R, Smith CB, Adelson KB, Gonsky JP, Egorova N, Franco R, Bickell NA. Pintova S, et al. JCO Oncol Pract. 2020 Mar;16(3):e290-e297. doi: 10.1200/JOP.19.00381. Epub 2020 Jan 8. JCO Oncol Pract. 2020. PMID: 32048945 Clinical Trial.

2

Effects of a Communication Intervention Randomized Controlled Trial to Enable Goals-of-Care Discussions.

Bickell NA, Back AL, Adelson K, Gonsky JP, Egorova N, Pintova S, Lin JJ, Kozuch P, Bagiella E, Smith CB. Bickell NA, et al. Among authors: pintova s. JCO Oncol Pract. 2020 Sep;16(9):e1015-e1028. doi: 10.1200/OP.20.00040. Epub 2020 May 6. JCO Oncol Pract. 2020. PMID: 32374710 Clinical Trial.

3

Conducting Goals-of-Care Discussions Takes Less Time Than Imagined.

Pintova S, Leibrandt R, Smith CB, Adelson KB, Gonsky J, Egorova N, Franco R, Bickell NA. Pintova S, et al. JCO Oncol Pract. 2020 Dec;16(12):e1499-e1506. doi: 10.1200/JOP.19.00743. Epub 2020 Aug 4. JCO Oncol Pract. 2020. PMID: 32749930 Clinical Trial.

4

Impact of inpatient radiation on length of stay and health care costs.

Pintova S, Holcombe RF, Blacksburg S, Friedlander P. Pintova S, et al. J Community Support Oncol. 2015 Nov;13(11):399-404. doi: 10.12788/jcso.0183. J Community Support Oncol. 2015. PMID: 26863020

5

Adjuvant Chemotherapy Is Not Guided by Pathologic Treatment Effect After Neoadjuvant Chemotherapy in Pancreatic Cancer.

Gleeson EM, Leigh N, Golas BJ, Magge D, Sarpel U, Hiotis SP, Labow DM, Pintova S, Cohen NA. Gleeson EM, et al. Among authors: pintova s. Pancreas. 2021 Sep 1;50(8):1163-1168. doi: 10.1097/MPA.0000000000001881. Pancreas. 2021. PMID: 34714279

6

Sweet's syndrome in a patient with metastatic melanoma after ipilimumab therapy.

Pintova S, Sidhu H, Friedlander PA, Holcombe RF. Pintova S, et al. Melanoma Res. 2013 Dec;23(6):498-501. doi: 10.1097/CMR.0000000000000017. Melanoma Res. 2013. PMID: 24113862

7

ME-143 Is Superior to Genistein in Suppression of WNT Signaling in Colon Cancer Cells.

Pintova S, Planutis K, Planutiene M, Holcombe RF. Pintova S, et al. Anticancer Res. 2017 Apr;37(4):1647-1653. doi: 10.21873/anticanres.11495. Anticancer Res. 2017. PMID: 28373425

8

An Unusual Course of Metastatic Gastroesophageal Cancer.

Smith WH, Pintova S, DiMaio CJ, Manolas P, Lee DS, Hiotis SP, Kartsonis M, Holcombe RF, Dharmarajan KV. Smith WH, et al. Among authors: pintova s. Case Rep Oncol Med. 2015;2015:941508. doi: 10.1155/2015/941508. Epub 2015 Dec 3. Case Rep Oncol Med. 2015. PMID: 26770853 Free PMC article.

9

Genistein combined with FOLFOX or FOLFOX-Bevacizumab for the treatment of metastatic colorectal cancer: phase I/II pilot study.

Pintova S, Dharmupari S, Moshier E, Zubizarreta N, Ang C, Holcombe RF. Pintova S, et al. Cancer Chemother Pharmacol. 2019 Sep;84(3):591-598. doi: 10.1007/s00280-019-03886-3. Epub 2019 Jun 15. Cancer Chemother Pharmacol. 2019. PMID: 31203390 Clinical Trial.

10

Sickle cell trait: is there an increased VTE risk in pregnancy and the postpartum?

Pintova S, Cohen HW, Billett HH. Pintova S, et al. PLoS One. 2013 May 22;8(5):e64141. doi: 10.1371/journal.pone.0064141. Print 2013. PLoS One. 2013. PMID: 23717554 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page